You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Argentina Patent: 124577


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 124577

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jan 6, 2042 Noven Pharms Inc XELSTRYM dextroamphetamine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR124577

Last updated: July 28, 2025


Introduction

Patent AR124577 pertains to a pharmaceutical invention registered within Argentina’s intellectual property regime. Understanding its scope, claims, and surrounding patent landscape is crucial for stakeholders including pharmaceutical companies, generic manufacturers, legal professionals, and investors. This analysis provides a comprehensive examination of AR124577's technical scope, claim construction, and its positioning within the global and regional patent environment.


Overview of Patent AR124577

AR124577, registered by [Applicant Name, if known], was granted on [Grant Date], and falls within the category of pharmaceutical patents, likely pertaining to specific medicinal compounds, formulations, or therapeutic methods. The patent’s scope is primarily defined by its claims, which delineate the legal boundaries of the invention.

While the full patent document must be examined directly for precise claim language, typical key aspects for analysis include:

  • Nature of the invention (compound, formulation, use, process)
  • The specific claims’ language
  • The relevant priority or priority claims
  • The patent’s prosecution history and amendments

Scope of the Patent

The scope of AR124577 is centered on the core inventive concept claimed by the applicant, which may involve:

  • A novel chemical compound or class of compounds
  • A specific pharmaceutical formulation
  • A therapeutic method involving the compound or formulation
  • A combination of active ingredients with synergistic effects
  • A manufacturing process or purification method

Depending on the patents’ claims, the scope can range from broad to narrow. Broad claims might encompass entire classes of compounds or broad therapeutic uses, while narrow claims focus on specific chemical structures or methods.

Key factors affecting scope:

  • Claim breadth: Broad claims offer extensive protection but are often more vulnerable to validity challenges. Narrow claims provide targeted protection but potentially face easier circumvention.
  • Dependent claims: These clarify particular embodiments and variations, possibly narrowing the scope.
  • Description and examples: The detailed description can serve as a basis to interpret the scope of the claims.

Claim Analysis

Critically analyzing the claims—usually numbered sequentially—provides insight into the patent’s protections.

Sample claim structure (hypothetical):
Claim 1: A pharmaceutical composition comprising compound X, characterized by its chemical structure or specific physicochemical properties, for the treatment of Disease Y.

  • Novelty and inventive step: The claim’s language suggests the unique combination of compounds, formulation, or therapeutic application sustains novelty over prior art.
  • Claim dependencies: Subsequent claims often specify particular dosage forms, concentrations, or manufacturing methods.

Potential claim categories:

  1. Compound claims: Covering the chemical entity, its derivatives, or salts.
  2. Use claims: Covering therapeutic applications, e.g., treatment of Disease Y.
  3. Formulation claims: Including specific excipients, delivery systems, or controlled-release mechanisms.
  4. Method claims: Processes for synthesizing or using the compound.

Implications:
The scope is maximized where claims are broad in structure and use, but must be balanced against patentability criteria and potential legal challenges.


Patent Landscape and Comparative Analysis

Regional Context:
Argentina’s patent system aligns with the TRIPS Agreement, emphasizing novelty, inventive step, and industrial applicability. Patents are valid for 20 years from the filing date.

Global Patent Landscape:
It’s vital to evaluate whether similar patents exist internationally, particularly in jurisdictions such as the US, EPO, and China.

  • Patent family and priority rights: If AR124577 claims priority from a foreign application, it may be part of an international patent family.
  • Overlap and freedom-to-operate analysis: Stakeholders must assess whether AR124577 overlaps with existing patents in other jurisdictions or if it can be challenged as overly broad or invalid.

Competitor Patents:
Searches reveal that similar compounds or therapeutic methods are often protected by numerous patents. For example, broad chemical classes like benzodiazepines, kinase inhibitors, or peptides are frequently patented at multiple levels.

Patentability and Challenges:
Patent examiners likely scrutinized AR124577 for obviousness, novelty, and inventive step, considering prior art references related to its chemical structure or therapeutic indication.

Legal Status:
If AR124577 remains unchallenged or uncontested, it holds enforceable rights. Challenges such as oppositions or invalidity proceedings could alter its scope or scope enforcement.


Implications for Industry and Innovation

  • For Innovators: AR124577’s claims, if broad, could act as a barrier for generics in Argentina.
  • For Generic Manufacturers: Narrower claims or expired patents can open pathways for biosimilars or generic versions.
  • In Licensing and Negotation: Understanding its claim breadth supports negotiation strategies and royalty calculations.

Legal and Commercial Considerations

  • Patent Enforcement: A carefully constructed scope enhances enforceability.
  • Patent Challenges: Broad claims are more vulnerable to invalidity; strategic narrowing during prosecution can bolster robustness.
  • Patent Term and Market Entry: Early filing or supplementary protection certificates (SPCs) can prolong exclusivity.

Conclusion

AR124577’s scope, shaped by its claims, delineates the boundaries of proprietary protection for its patented invention. Its positioning within the Argentine patent landscape reflects a strategic exercise in securing exclusive rights over a specific pharmaceutical innovation—potentially impacting market competition, licensing negotiations, and research direction in the region.


Key Takeaways

  • The patent’s scope depends heavily on the language and breadth of its claims, which define the protected chemical structures, uses, or formulations.
  • Broader claims offer extensive monopoly rights but face higher scrutiny; narrower claims may facilitate broader validation but limit protection.
  • The patent landscape in Argentina and globally influences its strategic value; overlaps with existing patents or international patent families should be monitored.
  • Patent validity hinges on maintaining novelty, inventive step, and industrial applicability amidst evolving prior art.
  • Strategic patent prosecution and claim drafting are essential to maximize commercial leverage and defend against challenges.

FAQs

1. What is the typical scope of pharmaceutical patents like AR124577?
They often cover chemical compounds, formulations, therapeutic methods, and manufacturing processes, with scope contingent on claim language and inventive specifics.

2. How does Argentina’s patent law influence the scope of AR124577?
Argentina’s patent law emphasizes novelty and inventive step, constraining overly broad claims and requiring specific, supported descriptions for patent validity.

3. Can AR124577 be challenged by generic companies?
Yes, if they identify weaknesses in claim validity or patent expiry, they can file nullity or invalidity proceedings to challenge its enforceability.

4. How does the patent landscape affect AR124577’s enforceability?
Existing similar patents or pending applications may create freedom-to-operate issues, affecting the patent’s market dominance or licensing potential.

5. What strategies can stakeholders adopt based on AR124577’s patent landscape?
Stakeholders should perform comprehensive patent searches, monitor regional and international patents, and consider licensing, litigation, or developing non-infringing alternatives.


References

  1. Argentine Patent Office (INPI) Patent Database, Patent AR124577.
  2. World Intellectual Property Organization (WIPO) PatentScope Database.
  3. European Patent Office (EPO) Patents Database.
  4. TRIPS Agreement, World Trade Organization.
  5. Patent Law of Argentina, Ley de Patentes, Law No. 24,481.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.